Kidney Cancer Section Head, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center
Faculty Member, Memorial Sloan Kettering Cancer Center
Drs. Robert J Motzer and Ethan Basch compare the costs, efficacy, and patient experience of targeted therapies for metastatic renal cell carcinoma.
Read the full article here.
We conduct non-partisan, independent research, and make our work accessible and informative to policymakers and the general audience alike. Browse our featured research or explore our work by article type.